2014

Karyopharm Announces Addition to the NASDAQ Biotechnology Index
December 15, 2014


Relypsa Announces FDA Acceptance of New Drug Application for Patiromer for Oral Suspension to Treat Hyperkalemia
December 15, 2014


CardioKinetix Completes $50 Million Financing and Signs Agreement with Edwards Lifesciences, Including Exclusive Option to Purchase
December 9, 2014


VaxInnate Initiates Phase 1b/2 Clinical Trial of Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, in Elderly
December 8, 2014


CareFusion and Kit Check to Help Providers Save Time and Improve Medication Safety from the Pharmacy to the OR
December 8, 2014


MEI Pharma Reports Significant Clinical Activity in Phase II Study of Pracinostat in Front Line Acute Myeloid Leukemia
December 8, 2014


MEI Pharma Completes Enrollment in Phase II Study of Pracinostat in Front Line Acute Myeloid Leukemia
December 2, 2014


James R. Tobin, Former CEO of Boston Scientific, Joins Oxford Immunotec Board of Directors
December 2, 2014


IlluminOss Medical Announces Conditional FDA Approval for Clinical Trials of Groundbreaking Photodynamic Bone Stabilization System in the U.S.
November 18, 2014


Relypsa Announces Key Data Presented at ASN on Long-Term Chronic Treatment and Early Onset of Action With Patiromer for Oral Suspension
November 17, 2014


Chimerix's Brincidofovir Selected for Use in Ebola Clinical Trial in West Africa by International Consortium
November 13, 2014


Spiracur Secures $16M from GE Capital to Expand Sales and R&D Efforts
November 12, 2014


TigerText Announces Integration with MobileIron to Deliver Secure Messaging
November 12, 2014


Intarcia and Servier Sign Ex-U.S. Partnership for ITCA 650 in Diabetes; Intarcia Retains Independence & Full Control of the U.S. & Japan
November 12, 2014


Kit Check Install Stories: Children’s Hospital of The King’s Daughters
November 12, 2014


VaxInnate Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, Meets Phase 1 Seasonal Influenza Endpoints
November 11, 2014


Awarepoint Names New CEO
November 10, 2014


Relypsa Announces Multiple Patiromer for Oral Suspension Abstracts to be Presented at American Society of Nephrology Annual Meeting 2014
November 4, 2014


Oxford Immunotec Reports Third Quarter 2014 Financial Results
November 4, 2014


Chimerix Names Two New Executives: Peter Payne as Senior Vice President, Business Development and Corporate Strategy, and Roberto Guzman, JD, MBA, MCLFS, as Vice President, Corporate Compliance
November 3, 2014


Relypsa Names Scott Garland Senior Vice President and Chief Commercial Officer
November 3, 2014


Chimerix Provides Update on Research and Development Progress
October 16, 2014


Concert Pharmaceuticals Presents Positive Data from Multiple Dose Phase 1 Clinical Trial of CTP-354, Lead Candidate for the Treatment of Spasticity
October 13, 2014


Kit Check Announces RFID Seal Tags in Collaboration with Health Care Logistics for Hospital Pharmacy Kit Safety
October 08, 2014


Solaris Hospice Replaces Unsecure Email and Voicemail with TigerText Secure Messaging
October 7, 2014


Actavis to Acquire Durata Therapeutics, Inc.
October 6, 2014


Chimerix Announces Emergency Investigational New Drug Applications for Brincidofovir Authorized by FDA for Patients With Ebola Virus Disease
October 6, 2014


Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results
October 1, 2014


Concert Pharmaceuticals Announces Initiation of CTP-730 Phase 1 Clinical Trial Under Celgene Collaboration
September 17, 2014


Intarcia Reveals New Insights at EASD Meeting Characterizing the Burden of Poor Control and Non-Adherence to Anti-Diabetic Therapies
September 17, 2014


Relypsa Announces New Employment Inducement Grants
September 16, 2014


Relypsa Announces New Analysis of Phase 3 Data Demonstrating Patiromer's Ability to Rapidly Correct, and Prevent Recurrence of, Hyperkalemia in Heart Failure and Non-Heart Failure Patients
September 15, 2014


7 recent vendor contracts included KitCheck
September 12, 2014


Kit Check Passes 100 Hospital Customer Mark
September 9, 2014


Ventura County Medical Center Selects TigerText for HIPAA Compliant Nurse-to-Physician Communication
September 9, 2014


Spiracur’s SNaP Wound Care System Awarded Coverage by Health Care Services Corporation
September 4, 2014


Kit Check Tracks Two Million Hospital Medications With RFID
September 3, 2014


Chimerix's Brincidofovir Has in Vitro Activity Against Ebola
September 3, 2014


MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome
September 2, 2014


Chimerix and BARDA Announce Continued Partnership in the Development of Brincidofovir for Smallpox
September 2, 2014


Chimerix's Brincidofovir Selected for Two Oral Presentations Highlighting Resistance Data in CMV and Adenovirus at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
September 2, 2014


TigerText Growth Accelerates in First Half of 2014 as Message Volume Surges 750%
August 27, 2014


Concert Pharmaceuticals Achieves $2 Million Milestone for AVP-786 Under Avanir Pharmaceuticals Collaboration
August 26, 2014


Spiracur Announces Renewal Contract with Novation for Advanced, Mechanically-Powered, Disposable Negative Pressure Wound Care Products
August 7, 2014


Chimerix Announces Second Quarter 2014 Financial Results
August 7, 2014


Karyopharm Therapeutics Reports Second Quarter Financial Results for 2014
August 7, 2014


Durata Therapeutics Reports Second Quarter 2014 Financial Results
August 7, 2014


Kit Check Adds Medication Shortage Management Features To Improve Pharmacy Kit Processing Efficiency
August 6, 2014


Oxford Immunotec Announces Purchase Of Assets Of Boulder Diagnostics Inc.
August 5, 2014


Versartis Reports Second Quarter 2014 Financial Results
August 5, 2014


Oxford Immunotec Reports Second Quarter 2014 Financial Results
Aug. 5, 2014


New Data on Chimerix's Brincidofovir Supports Safety and Antiviral Activity Against Multiple Life-Threatening DNA Viruses in Organ Transplant Recipients
July 31, 2014


Durata Therapeutics Enters Into an Exclusive License and Supply Agreement With Angelini to Commercialize Dalbavancin in Certain European Territories, Russia and Turkey
July 30, 2014


LifePoint Hospitals' Fauquier Health, Selects TigerText as its Facility-Wide Secure Messaging Solution
July 22, 2014


Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386
July 21, 2014


Durata Therapeutics Announces the U.S. Launch of DALVANCE™
July 18, 2014


CareDx Announces Pricing of its IPO and Completion of its First Day of Trading
July 17, 2014


Concert Pharmaceuticals Announces FDA Lifts Partial Clinical Hold for CTP-354, A Novel Drug Candidate for Spasticity
July 16, 2014


Awarepoint awareAssets version 3.0 Now Available
July 8, 2014


Chimerix Announces Three Abstracts to be Presented at the 2014 World Transplant Congress
July 8, 2014


Concert Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for CTP-499
July 8, 2014


ReShape Medical® Submits PMA Application to FDA for Non-Surgical Weight Loss Device
July 1, 2014


Pharmacy Pricing & Benefits Analysis Platform Truveris Raised Another $12.75M
June 27, 2014


Versartis Presents Positive Six Month VRS-317 Phase 2a Clinical Study Results
June 23, 2014


HIPAA Encryption for iPhones and Android Phones
June 17, 2014


Intarcia Presents Interim Phase 3 Data at ADA Showing ITCA 650, A Once Yearly GLP-1, Markedly Reduces Blood Sugar in Patients With Very Poorly Controlled Diabetes
June 15, 2014


MEI Pharma Reports High Response Rates In Phase II Study Of Pracinostat In Front Line Acute Myeloid Leukemia
June 10, 2014


Relypsa Secures Loan Facility of Up to $35 Million
June 2, 2014


Kit Check Announces New RFID Scanning Station, Little Blue Box is Smaller, Lighter, Provided Free for Users
June 2, 2014


Chimerix Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock
May 27, 2014


Chimerix Regains Worldwide Rights to CMX157
May 16, 2014


QPID Health Secures $12.3M Series B Funding
May 6, 2014


Concert Pharmaceuticals Presents Positive 48-Week Results from Phase 2 Clinical Trial of CTP-499 in Diabetic Kidney Disease
April 25, 2014


Relypsa, Inc. Announces Closing of Public Offering of Common Stock
April 16, 2014


Awarepoint Humidity-Sensing Tag Now Available
April 15, 2014


Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
April 9, 2014


CardioKinetix Releases One-Year Clinical Data Showing Consistent, Compelling Positive Results for Patients Treated with Minimally Invasive Structural Heart Device for Heart Failure
April 7, 2014


Cardinal Health Expands Portfolio of Physician Preference Items
April 2, 2014


Premier, Inc. Identifies Kit Check as "Technology Breakthrough Product" – awards exclusive agreement for pharmacy kit medication tracking solution
April 2, 2014


Relypsa Names Sylvia R. Wheeler V.P. Investor Relations and Corporate Affairs
April 2, 2014


Spiracur Announces FDA Clearance of its SNaP Wound Care System Dressings with Hyperbaric Oxygen Therapy
April 1, 2014


Intarcia Secures Second Landmark Private Financing of $200 Million – Strengthens Position To Complete Phase 3, Prepare For Launch, and Build Pipeline
April 1, 2014


Chimerix Appoints Lisa Ricciardi to Board of Directors
April 1, 2014


Convergence and Evotec form integrated pain alliance
March 31, 2014


TigerText Dangles $1M Guarantee Against HIPAA Violations
March 31, 2014


AccessClosure Launches the Next-Generation Mynx Ace Vascular Closure Device at Annual ACC Meeting
March 29, 2014


Kit Check adds Medi-Span Integration, New Safety Features for Pharmacy Kit Processing
March 27, 2014


Versartis Announces Pricing of Its Initial Public Offering
March 20, 2014


Kit Check Hires Elizabeth Thomas as Director of Marketing
March 20, 2014


VaxInnate Begins Phase I Clinical Trial to Evaluate Quadrivalent Vaccine for Prevention of Seasonal Flu
March 19, 2014


Chimerix to Provide Brincidofovir to Josh Hardy as First Patient in New Open-Label Study in Patients With Adenovirus Infections
March 11, 2014


Intarcia Appoints Jay Smith Head of Customer Experience & Outcomes
February 26, 2014


Optum Acquires Majority Interest in Audax Health Solutions
February 19, 2014


Versartis Secures $55 Million in Series E Financing
February 18, 2014


Awarepoint Drives Growth and Moves Client Base to Next Generation Platform
February 13, 2014


Concert Pharmaceuticals Announces Pricing of Initial Public Offering
February 13, 2014


VaxInnate Receives $2.1 million from New Jersey’s Technology Business Tax Certificate Transfer Program
January 28, 2014


TigerText Caps Record Year with $21 Million Series B Investment to Accelerate Market Penetration
January 27, 2013


Spiracur Secures TGA Approval for SNaP Wound Care System and Announces Distribution Partnership in Australia
January 14, 2014


Direct Flow Medical®, Inc. Receives CE Mark For First Fully Repositionable 29 mm Transcatheter Aortic Valve System
January 9, 2014


Direct Flow Medical®, Inc. Completes Enrollment In U.S. Salus Feasibility Trial Of Transcatheter Aortic Heart Valve System
January 9, 2014


Convergence Pharmaceuticals and Consortium Partners Win European Commission FP7 Grant for the PROPANE Project
January 8, 2014


ZIO® Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine
January 2, 2014